A double-blind, randomised, two-period crossover study investigating ticagrelor versus clopidogrel in combination with aspirin in healthy volunteers

Trial Profile

A double-blind, randomised, two-period crossover study investigating ticagrelor versus clopidogrel in combination with aspirin in healthy volunteers

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2015

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Thromboembolism
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 28 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top